Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib - Université de Lille
Article Dans Une Revue BMC Cancer Année : 2014

Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib

Résumé

TRPM8 is a cold sensor that is highly expressed in the prostate as well as in other non-temperature-sensing organs, and is regulated by downstream receptor–activated signaling pathways. However, little is known about the intracellular proteins necessary for channel function. Here, we identify two previously unknown proteins, which we have named “TRP channel–associated factors” (TCAFs), as new TRPM8 partner proteins, and we demonstrate that they are necessary for channel function. TCAF1 and TCAF2 both bind to the TRPM8 channel and promote its trafficking to the cell surface. However, they exert opposing effects on TRPM8 gating properties. Functional interaction of TCAF1/TRPM8 also leads to a reduction in both the speed and directionality of migration of prostate cancer cells, which is consistent with an observed loss of expression of TCAF1 in metastatic human specimens, whereas TCAF2 promotes migration. The identification of TCAFs introduces a novel mechanism for modulation of TRPM8 channel activity.
Fichier principal
Vignette du fichier
1471-2407-14-939.pdf (1.47 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04039024 , version 1 (13-03-2024)

Identifiants

Citer

Alessandra Fiorio Pla, Alessia Brossa, Michela Bernardini, Tullio Genova, Guillaume Grolez, et al.. Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib. BMC Cancer, 2014, 14 (1), pp.939. ⟨10.1186/1471-2407-14-939⟩. ⟨hal-04039024⟩

Collections

UNIV-LILLE
14 Consultations
1 Téléchargements

Altmetric

Partager

More